Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) rose 41.3% during trading on Friday. The company traded as high as $0.2120 and last traded at $0.2120. Approximately 1,200 shares were traded during mid-day trading, a decline of 94% from the average daily volume of 20,342 shares. The stock had previously closed at $0.15.
Cell MedX Stock Performance
The stock’s 50 day simple moving average is $0.24 and its two-hundred day simple moving average is $0.29.
Cell MedX Company Profile
Cell MedX Corp. is a medical technology company focused on developing non-invasive therapeutic products intended to support health and wellness. The company has promoted its e-balance technology, a device-based therapy designed to deliver controlled electrical stimulation as part of an approach to managing certain health conditions.
Cell MedX has historically positioned e-balance for use in areas including diabetes management, pain relief, stress reduction and general wellness. The technology has been offered through healthcare and wellness settings, although publicly available information about the company’s current products, commercial operations and geographic reach is limited.
Cell MedX is based in the United States and trades on the OTC Markets under the symbol CMXC.
See Also
- Five stocks we like better than Cell MedX
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
